脑出血周围水肿与临床结局:系统评价与Meta分析
该系统评价与Meta分析纳入20项研究共6633例脑出血患者,评估血肿周围水肿(PHE)及其增长与功能结局的关联。合并效应量为1.05(95%CI 1.02-1.08;p<0.00),但死亡率(1.01;95%CI 0.90-1.14)和功能结局(1.04;95%CI 1.02-1.07)的效应均弱。PHE体积和PHE增长的效应量分别为1.04(95%CI 1.01-1.07)和1.14(95%CI 1.04-1.25)。结论认为PHE增长在发病72小时内可能影响稍大,但PHE测量方法差异大、异质性和评估时间点不同限制了确定性结论。
要点
- 20项研究共6633例脑出血患者,PHE总体合并OR为1.05(95%CI 1.02-1.08;p<0.00)。
- PHE对死亡率影响弱:OR 1.01(95%CI 0.90-1.14),置信区间跨1。
- PHE对功能结局影响弱:OR 1.04(95%CI 1.02-1.07);90天评估OR 1.06(95%CI 1.02-1.11),住院期间评估OR 1.04(95%CI 1.00-1.08)。
- PHE体积OR 1.04(95%CI 1.01-1.07),PHE增长OR 1.14(95%CI 1.04-1.25),增长的影响可能稍大。
- 除PHE增长外,各研究间异质性较大;PHE测量方法差异大和评估时间点不同限制确定性结论。
适用人群与场景
- 脑出血(ICH)患者,纳入使用logistic回归分析PHE或其增长与功能结局关联的研究。
研究设计与关键结果
- 系统评价与Meta分析,纳入20项研究,共6633例患者,检索主要数据库至2020年12月。
- 总体合并效应量OR 1.05(95%CI 1.02-1.08;p<0.00)。
- 死亡率OR 1.01(95%CI 0.90-1.14);功能结局OR 1.04(95%CI 1.02-1.07);90天评估OR 1.06(95%CI 1.02-1.11);住院期间评估OR 1.04(95%CI 1.00-1.08)。
- PHE体积OR 1.04(95%CI 1.01-1.07);PHE增长OR 1.14(95%CI 1.04-1.25)。
- 除PHE增长外,研究间异质性较大。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(纳入使用logistic回归的研究),采用DerSimonian-Laird随机效应模型,研究质量用Newcastle-Ottawa量表由三名独立评价者评估。
- 局限:PHE测量方法差异大、研究间异质性(除PHE增长外)以及不同研究评估时间点不同,限制了确定性结论。
对床旁实践的改变
- 作者认为,发病后72小时内PHE体积对脑出血后功能结局和死亡率影响微弱,而PHE增长在该时间窗内影响可能稍大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Perihematomal edema (PHE) has been proposed as a radiological marker of secondary injury and therapeutic target in intracerebral hemorrhage (ICH). We conducted a systematic review and meta-analysis to assess the prognostic impact of PHE on functional outcome and mortality in patients with ICH.
METHODS: We searched major databases through December 2020 using predefined keywords. Any study using logistic regression to examine the association between PHE or its growth and functional outcome was included. We examined the overall pooled effect and conducted secondary analyses to explore the impact of individual PHE measures on various outcomes separately. Study quality was assessed by three independent raters using the Newcastle-Ottawa Scale. Odds ratios (per 1-unit increase in PHE) and their confidence intervals (CIs) were log transformed and entered into a DerSimonian-Laird random-effects meta-analysis to obtain pooled estimates of the effect.
RESULTS: Twenty studies (n = 6633 patients) were included in the analysis. The pooled effect size for overall outcome was 1.05 (95% CI 1.02-1.08; p < 0.00). For the following secondary analyses, the effect size was weak: mortality (1.01; 95% CI 0.90-1.14), functional outcome (1.04; 95% CI 1.02-1.07), both 90-day (1.06; 95% CI 1.02-1.11), and in-hospital assessments (1.04; 95% CI 1.00-1.08). The effect sizes for PHE volume and PHE growth were 1.04 (95% CI 1.01-1.07) and 1.14 (95% CI 1.04-1.25), respectively. Heterogeneity across studies was substantial except for PHE growth.
CONCLUSIONS: This meta-analysis demonstrates that PHE volume within the first 72 h after ictus has a weak effect on functional outcome and mortality after ICH, whereas PHE growth might have a slightly larger impact during this time frame. Definitive conclusions are limited by the large variability of PHE measures, heterogeneity, and different evaluation time points between studies.
参考来源
- Marchina S, Trevino-Calderon JA, Hassani S, et al. Perihematomal Edema and Clinical Outcome After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Neurocrit Care. 2022. PMID: 35578090. doi:10.1007/s12028-022-01512-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。